View Full Paper

Owner Consent Verified
Report 4.2

Resilience And Continuity in Supply Chain Resilience for Pharmaceutical Firms: 2020–2028 Trends

19
Pages
Harvard
Style
~ 20–29 mins
Reading Time
Leadership NLP IoT
Abstract

This report investigates “Resilience And Continuity in Supply Chain Resilience for Pharmaceutical Firms: 2020–2028 Trends” using a propensity score matching. Through a institutional lens, the analysis integrates multi-source data to derive a practical decision framework for researchers and practitioners.

Download PDF Order Similar Paper Save

Resilience And Continuity in Supply Chain Resilience for Pharmaceutical Firms: 2020–2028 Trends

ABSTRACT
Resilience And Continuity in Supply Chain Resilience for Pharmaceutical Firms: 2020–2028 Trends is unpacked across themes: usability, costs, benefits, and interoperability. Limitations and future research paths are noted.
1
Open full preview
Related Papers
Browse all
23 Pages 4.8
Digital Transformation and Cost–Benefit Analysis among City Planners — A Delphi study
Governance HCI Cybersecurity
View Paper
15 Pages 4.4
Interoperability in AIOps for Insurance Underwriters: Evidence from Southeast Asia
IoT Cold Chain CV
View Paper
7 Pages 4.9
Battery Recycling Adoption in University Students: Change Management — Evidence from Benelux
Cold Chain AIOps Esports
View Paper